Study estimates a 23% increase in copd by 2050, representing 600 million patients globally

Published in the journal of the american medical association network open, study estimates  global copd burden from 2020 through 2050 study projects disproportionate growth in copd among women and low-middle income regions san diego, dec. 07, 2023 (globe newswire) -- resmed (nyse: rmd, asx: rmd) today announced the results of a study on the global burden of chronic obstructive pulmonary disease (copd) through 2050. published in the journal of the american medical association (jama) network open, the study found that copd prevalence among those 25 years and older is expected to increase by 23% from 2020 to 2050, with the largest growth projected among women and within low- and middle-income countries.
RMD Ratings Summary
RMD Quant Ranking